Abstract
Antisense experiments are often complicated by the lack of reliable methods for selecting effective antisense sequences. Chimeric oligodeoxynucleotide (ODN) libraries and ribonuclease H (RNase H) were used to identify regions on the 1253 nucleotide angiotensin type-1 receptor (AT1) mRNA that are accessible to hybridization with antisense ODNs. Phosphorothioate antisense ODNs targeted against accessible sites reduced AT1 receptor levels by at least 50% in cell culture. ODNs to 4 sites produced a 70% to 80% reduction. In contrast, most sequences targeted between accessible sites were ineffective. When injected into the brains of rats, ODNs targeted to accessible sites reduced AT1 (by 65%) but not AT2 receptor levels. Additionally, AT1 receptor function as measured by agonist-induced water intake, was significantly attenuated in these rats. ODNs directed between accessible sites were ineffective at suppressing water intake. RNA mapping can be applied to any RNA target to facilitate selection of multiple, active antisense sequences for cell culture and in vivo experiments.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Raffa, R.B. and Porreca, F. 1996 Antisense strategies for the study of receptor mechanisms. Chapman & Hall, London.
Agrawal, S. 1996 Antisense therapeutics. Humana Press, Totawa, NJ.
Agrawal, S. 1995 Delivery strategies for antisense oligonucleotide therapeutics. CRC Press, Boca Raton, FL.
Szymkoswki, D.E. 1996 Developing antisense oligonucleotides from the laboratory to clinical trials. Drug Discovery Today 1: 415–428.
Gewirtz, A.M., Stein, C.A. and Glazer, P.M. 1996 Facilitating oligonucleotide delivery: Helping antisense deliver on its promise. Proc. Natl. Acad. Sci. USA 93: 3161–3163.
Peyman, A., Helsberg, M., Kretzschmar, G., Mag, M., Grabley, S. and Uhlmann, E. 1995 Inhibition of viral growth by antisense olginucleotides directed against the IE110 and the UL30 mRNA of Herpes Simplex Virus type-l. Biol. Chem 376: 195–198.
Monia, B.P., Johnston, J.F., Geiger, T., Muller, M. and Fabbro, D. 1996 Antitumor activity of a phosphorothioate antisense oligodeoxynucleotide targeted against C-raf kinase. Nat. Med. 2: 668–675.
Dean, N.M., McKay, R., Condon, T.P. and Bennett, C.F. 1994 Inhibition of protein kinase C-α expression in human A549 cells by antisense oligonucleotides inhibits induction of intercellular adhesion molecule 1 (ICAM-1) mRNA by phorbol esters. J. Biol. Chem. 269: 16416–16424.
Ho, S.P., Britton, D.H.O., Stone, B.A., Behrens, D.L., Leffet, L.M., Hobbs, F.W. et al. 1996 Potent antisense oligonucleotides to the human multidrug resistance-1 mRNA are rationally selected by mapping RNA-accessible sites with oligonucleotide libraries. Nucl. Acids Res. 24: 1901–1907.
Condon, T.P. and Bennett, C.F. 1996 Altered mRNA splicing and inhibition of human E-selectin expression by an antisense oligonucleotide in human umbilical vein endothelial cells. J. Biol. Chem. 271: 30398–30403.
Monia, B.P., Lesnik, E.A., Gonzalez, C., Lima, W.F., McGee, D., Guinosso, C.J. et al. 1993 Evaluation of 2′-modified oligonucleotides containing 2′-deoxy gaps as antisense inhibitors of gene expression. J. Biol. Chem. 268: 14514–14522.
Giles, R.V., Spiller, D.G. and Tidd, D.M. 1995 Detection of ribonuclease H-generated mRNA fragments in human leukemia cells following reversible membrane permeabilization in the presence of antisense oligodeoxynucleotides. Antisense Res. Dev. 5: 23–31.
Inoue, H., Hayase, Y., Iwai, S. and Ohtsuka, E. 1987 Sequence-dependent hydrolysis of RNA using modified oligonucleotide splints and RNase H. FEBS Lett. 215: 327–330.
Crooke, S.T., Lemonidis, K.M., Neilson, L., Griffey, R., Lesnik, E.A. and Monia, B.P. 1995 Kinetic characteristics of Escherichia coli RNase H: cleavage of various antisense oligonucleotide-RNA duplexes. Biochemistry Journal 312: 599–608.
Lima, W.F., Mohan, V. and Crooke, S.T. 1997 The influence of antisense oligonucleotide-induced RNA structure on Escherichia coli RNase H1 activity. J. Biol. Chem. 272: 18191–18199.
Sakai, R.R., He, P.F., Yang, X.D., Ma, L.Y., Guo, Y.F., Reilly, J.J. et al. 1994 Intracerebroventricular administration of AT, receptor antisense oligonucleotides inhibits the behavioral actions of angiotensin II. J. Neurochem. 62: 2053–2056.
Lima, W.F., Brown-Driver, V., Fox, M., Hanecak, R. and Bruice, T.W. 1997 Combinatorial screening and rational optimization for hybridization to folded hepatitis C virus RNA of oligonucleotides with biological antisense activity. J. Biol. Chem. 272: 626–638.
Birikh, K.R., Berlin, Y.A., Soreq, H. and Eckstein, F. 1997 Probing accessible sites for ribozymes on human acetylcholinesterase RNA. RNA 3: 429–437.
Milner, N., Mir, K.U. and Southern, E.M. 1997 Selecting effective antisense reagents on combinatorial oligonucleotide arrays. Bio/Technology 15: 537–544.
Lieber, A. and Strauss, M. 1995 Selection of efficient cleavage sites in target RNAs by using a ribozyme expression library. Mol. Cell. Biol. 15: 540–551.
Chiu, A.T., Dunscomb, J., McCall, D.E., Benfield, P., Baubonis, W. and Sauer, B. 1993 Characterization of angiotensin AT1 a receptor isoform by its ligand binding signature. Regulatory Peptides 44: 141–147.
Chiu, A.T., Dunscomb, J., McCall, D.E., Benfield, P., Baubonis, W. and Sauer, B. 1993 Characterization of angiotensin AT1 a receptor isoform by its ligand binding signature. Regul. Pept. 44: 141–147.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Ho, S., Bao, Y., Lesher, T. et al. Mapping of RNA accessible sites for antisense experiments with oligonucleotide libraries. Nat Biotechnol 16, 59–63 (1998). https://doi.org/10.1038/nbt0198-59
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/nbt0198-59
This article is cited by
-
Antisense Oligonucleotides: Treating Neurodegeneration at the Level of RNA
Neurotherapeutics (2013)
-
Antisense DNA parameters derived from next-nearest-neighbor analysis of experimental data
BMC Bioinformatics (2010)
-
Selection of antisense oligonucleotides based on multiple predicted target mRNA structures
BMC Bioinformatics (2006)
-
Antisense therapy for cancer
Nature Reviews Cancer (2005)